BIRC3 and Huntington disease: Expression of endogenous inhibitor of apoptosis proteins, IAP1 and XIAP, is markedly reduced in HD post-mortem human brain tissue, pointing to IAP-mediated regulation of caspase activity as a potential therapeutic target in HD (Goffredo et al., 2005).